enow.com Web Search

  1. Ads

    related to: new prostate cancer drugs

Search results

  1. Results from the WOW.Com Content Network
  2. Enzalutamide - Wikipedia

    en.wikipedia.org/wiki/Enzalutamide

    Enzalutamide, sold under the brand name Xtandi, is a nonsteroidal antiandrogen (NSAA) medication which is used in the treatment of prostate cancer. [2] [9] It is indicated for use in conjunction with castration in the treatment of metastatic castration-resistant prostate cancer (mCRPC), [2] nonmetastatic castration-resistant prostate cancer, [2] and metastatic castration-sensitive prostate ...

  3. STAMPEDE (clinical trial) - Wikipedia

    en.wikipedia.org/wiki/STAMPEDE_(clinical_trial)

    Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE) is a clinical trial investigating treatments for high risk or terminal prostate cancer. Recruitment started in 2005 and ended in 2022; as of January 2020, over 10,000 participants had joined the trial.

  4. New treatment ‘increases chance of survival’ for prostate ...

    www.aol.com/treatment-increases-chance-survival...

    Patients with advanced prostate cancer have a greater chance of survival if treated with a targeted cancer drug in addition to chemotherapy, according to a new study.

  5. Prostate Cancer Clinical Trial Pipeline Experiences Momentum ...

    lite.aol.com/tech/story/0022/20241015/9256275.htm

    New York, USA, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Prostate Cancer Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 150+ Companies Working in the Domain. Prostate cancer is one of the most common cancers among men worldwide, especially in aging populations.

  6. Tasquinimod - Wikipedia

    en.wikipedia.org/wiki/Tasquinimod

    Tasquinimod (ABR-215050, CID 54682876) is an experimental drug currently being investigated for the treatment of solid tumors. Tasquinimod has been mostly studied in prostate cancer, but its mechanism of action suggests that it could be used to treat other cancers. Castration-resistant prostate cancer (CRPC), formerly called hormone-resistant ...

  7. Janux Therapeutics surges on upbeat trial data for prostate ...

    www.aol.com/news/janux-therapeutics-surges-trial...

    The candidate, JANX007, reduced prostate-specific (PSA) antigen levels in a majority of the 23 patients who received the drug, the company said late on Monday, adding that deeper reductions were ...

  1. Ads

    related to: new prostate cancer drugs